Measuring Binding at the Putative Melatonin Receptor MT3.
2-iodoMCA-NAT
Binding
Brain
Fast kinetics
Melatonin
NQO2
Journal
Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
30
9
2022
pubmed:
1
10
2022
medline:
5
10
2022
Statut:
ppublish
Résumé
Melatonin, (N-acetyl-5-methoxytryptamine), is a neurohormone which possesses a wide range of biological effects. The effects mediated by melatonin are in part attributed to the antioxidant properties of the molecule. For a long time, melatonin had been described as a ligand of a putative "receptor" present in mammalian brains named MT
Identifiants
pubmed: 36180699
doi: 10.1007/978-1-0716-2593-4_30
doi:
Substances chimiques
Antioxidants
0
Ligands
0
Receptors, Melatonin
0
5-Methoxytryptamine
3VMW6141KC
Quinone Reductases
EC 1.6.99.-
Melatonin
JL5DK93RCL
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
283-289Informations de copyright
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Reppert SM, Weaver DR, Ebisawa T (1994) Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13:1177–1185. https://doi.org/10.1016/0896-6273(94)90055-8
doi: 10.1016/0896-6273(94)90055-8
pubmed: 7946354
Reppert SM, Weaver DR, Cassone VM et al (1995) Melatonin receptors are for the birds: molecular analysis of two receptor subtypes differentially expressed in chick brain. Neuron 15:1003–1015. https://doi.org/10.1016/0896-6273(95)90090-X
doi: 10.1016/0896-6273(95)90090-X
pubmed: 7576645
Reppert SM, Godson C, Mahle CD et al (1995) Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci U S A 92:8734–8738. https://doi.org/10.1073/pnas.92.19.8734
doi: 10.1073/pnas.92.19.8734
pubmed: 7568007
pmcid: 41041
Villas-Boas GR, Lavorato SN, Paes MM et al (2021) Modulation of the serotonergic receptosome in the treatment of anxiety and depression: a narrative review of the experimental evidence. Pharmaceuticals (Basel) 14:148. https://doi.org/10.3390/ph14020148
doi: 10.3390/ph14020148
Reppert SM, Weaver DR, Ebisawa T et al (1996) Cloning of a melatonin-related receptor from human pituitary. FEBS Lett 386:219–224. https://doi.org/10.1016/0014-5793(96)00437-1
doi: 10.1016/0014-5793(96)00437-1
pubmed: 8647286
Dufourny L, Levasseur A, Migaud M et al (2008) GPR50 is the mammalian ortholog of Mel1c: evidence of rapid evolution in mammals. BMC Evol Biol 8:105. https://doi.org/10.1186/1471-2148-8-105
doi: 10.1186/1471-2148-8-105
pubmed: 18400093
pmcid: 2323367
Gautier C, Guenin S-P, Riest-Fery I et al (2018) Characterization of the Mel1c melatoninergic receptor in platypus (Ornithorhynchus anatinus). PLoS One 13:e0191904. https://doi.org/10.1371/journal.pone.0191904
doi: 10.1371/journal.pone.0191904
pubmed: 29529033
pmcid: 5846726
Shabajee-Alibay P, Bonnaud A, Malpaux B et al (2021) A putative new melatonin binding site in sheep brain, MTx: preliminary observations and characteristics. J Pharmacol Exp Ther 27:JPET-AR-2021-000785. https://doi.org/10.1124/jpet.121.000785
doi: 10.1124/jpet.121.000785
Duncan MJ, Takahashi JS, Dubocovich ML (1988) 2-125Iiodomelatonin binding sites in hamster brain membranes: pharmacological characteristics and regional distribution. Endocrinology 122:1825–1833. https://doi.org/10.1210/endo-122-5-1825
doi: 10.1210/endo-122-5-1825
pubmed: 2834175
Duncan MJ, Takahashi JS, Dubocovich ML (1989) Characteristics and autoradiographic localization of 2-125Iiodomelatonin binding sites in Djungarian hamster brain. Endocrinology 125:1011–1018. https://doi.org/10.1210/endo-125-2-1011
doi: 10.1210/endo-125-2-1011
pubmed: 2752961
Paul P, Lahaye C, Delagrange P et al (1999) Characterization of 2-125Iiodomelatonin binding sites in Syrian hamster peripheral organs. J Pharmacol Exp Ther 290:334–340
pubmed: 10381796
Nosjean O, Nicolas J-P, Klupsch F et al (2001) Comparative pharmacological studies of melatonin receptors: mt1, mt2 and mt3/qr2. tissue distribution of mt3/qr2. Biochem Pharmacol 61:1369–1379. https://doi.org/10.1016/s0006-2952(01)00615-3
Nosjean O, Ferro M, Coge F et al (2000) Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 275:31311–31317. https://doi.org/10.1074/jbc.M005141200
doi: 10.1074/jbc.M005141200
pubmed: 10913150
Boutin JA, Ferry G (2019) Is there sufficient evidence that the melatonin binding site MT3 is quinone reductase 2? J Pharmacol Exp Ther 368:59–65. https://doi.org/10.1124/jpet.118.253260
doi: 10.1124/jpet.118.253260
pubmed: 30389722
Cecon E, Legros C, Boutin JA et al (2021) Journal of pineal research guideline for authors: defining and characterizing melatonin targets. J Pineal Res 70:e12712. https://doi.org/10.1111/jpi.12712
doi: 10.1111/jpi.12712
pubmed: 33332653
Molinari EJ, North PC, Dubocovich ML (1996) 2-[125I]Iodo-5-methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites. Eur J Pharmacol 301:159–168. https://doi.org/10.1016/0014-2999(95)00870-5
doi: 10.1016/0014-2999(95)00870-5
pubmed: 8773460
Vincent L, Cohen W, Delagrange P et al (2010) Molecular and cellular pharmacological properties of 5-methoxycarbonylamino-N-acetyltryptamine (MCA-NAT): a nonspecific MT3 ligand. J Pineal Res 48:222–229. https://doi.org/10.1111/j.1600-079X.2010.00746.x
doi: 10.1111/j.1600-079X.2010.00746.x
pubmed: 20210850
Mailliet F, Ferry G, Vella F et al (2005) Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme. Biochem Pharmacol 71:74–88. https://doi.org/10.1016/j.bcp.2005.09.030
doi: 10.1016/j.bcp.2005.09.030
pubmed: 16293234
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254. https://doi.org/10.1006/abio.1976.9999
doi: 10.1006/abio.1976.9999
pubmed: 942051
Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 51:660–672. https://doi.org/10.1111/j.1749-6632.1949.tb27297.x
doi: 10.1111/j.1749-6632.1949.tb27297.x
Cheng Y-C, Prusoff WH (1973) Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108. https://doi.org/10.1016/0006-2952(73)90196-2
doi: 10.1016/0006-2952(73)90196-2
pubmed: 4202581
Calamini B, Santarsiero BD, Boutin JA et al (2008) Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2. Biochem J 413:81–91. https://doi.org/10.1042/BJ20071373
doi: 10.1042/BJ20071373
pubmed: 18254726